CLINICAL_TRIALS
trial_result
· 2020-02-25
Clinical Trial Update: Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics [Phase 3]
Summary
Phase 3 clinical trial evaluating alicaforsen for pouchitis in patients unresponsive to antibiotics has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Atlantic Pharmaceuticals Ltd | Conditions: Pouchitis | Phase 3 | Status: COMPLETED | Results posted: 2020-02-25